Home NDC 72152-547-20 Zulresso
Product NDC 72152-547
Requested package NDC 72152-547-20
11-digit product format 721520547
Labeler code 72152
Product ID 72152-547_8115acb4-4050-4778-b516-e21ef742d451
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name brexanolone
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Sage Therapeutics, Inc.
Application NDA211371
Marketing category NDA
Marketing start 2019-06-17
Marketing end 0000-00-00
Substance BREXANOLONE
Active strength 5 mg/mL
DEA schedule CIV
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 8 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211371-001 ZULRESSO BREXANOLONE 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211371-001 10117951 2029-03-13 Drug product 2019-06-27 N211371-001 7635773 2029-03-13 Drug product 2019-06-27 N211371-001 8410077 2029-03-13 Drug product 2019-06-27 N211371-001 9200088 2029-03-13 Drug product 2019-06-27 N211371-001 9750822 2029-03-13 Drug product 2019-06-27 N211371-001 10322139 2033-01-23 Drug product 2019-06-27 N211371-001 10251894 2033-11-27 U-2552 2019-06-27 N211371-001 10940156 2037-03-08 U-2552 2021-04-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2019-06-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N211371-001 ZULRESSO 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2019-06-17 3a93d1ddd44b…
Observed Orange Book patent history# Patent history page 1 of 9 · 345 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N211371-001 10117951 2029-03-13 Drug product 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 7635773 2029-03-13 Drug product 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 8410077 2029-03-13 Drug product 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 9200088 2029-03-13 Drug product 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 9750822 2029-03-13 Drug product 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 10322139 2033-01-23 Drug product 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 10251894 2033-11-27 U-2552 2019-06-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211371-001 10940156 2037-03-08 U-2552 2021-04-07 c2088c7a36db…2026-09-14 22:38:34 2026-08 N211371-001 10117951 2029-03-13 Drug product 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 7635773 2029-03-13 Drug product 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 8410077 2029-03-13 Drug product 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 9200088 2029-03-13 Drug product 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 9750822 2029-03-13 Drug product 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 10322139 2033-01-23 Drug product 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 10251894 2033-11-27 U-2552 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211371-001 10940156 2037-03-08 U-2552 2021-04-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211371-001 10117951 2029-03-13 Drug product 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 7635773 2029-03-13 Drug product 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 8410077 2029-03-13 Drug product 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 9200088 2029-03-13 Drug product 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 9750822 2029-03-13 Drug product 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 10322139 2033-01-23 Drug product 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 10251894 2033-11-27 U-2552 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211371-001 10940156 2037-03-08 U-2552 2021-04-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211371-001 10117951 2029-03-13 Drug product 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 7635773 2029-03-13 Drug product 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 8410077 2029-03-13 Drug product 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 9200088 2029-03-13 Drug product 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 9750822 2029-03-13 Drug product 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 10322139 2033-01-23 Drug product 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 10251894 2033-11-27 U-2552 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211371-001 10940156 2037-03-08 U-2552 2021-04-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 10117951 2029-03-13 Drug product 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 7635773 2029-03-13 Drug product 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 8410077 2029-03-13 Drug product 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 9200088 2029-03-13 Drug product 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 9750822 2029-03-13 Drug product 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 10322139 2033-01-23 Drug product 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 10251894 2033-11-27 U-2552 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211371-001 10940156 2037-03-08 U-2552 2021-04-07 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 60 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 72152-547-20 72152054720 1 VIAL, SINGLE-DOSE in 1 CARTON (72152-547-20) > 20 mL in 1 VIAL, SINGLE-DOSE 2019-06-17 0000-00-00 No No Current